A detailed history of Ameriprise Financial Inc transactions in Bio Techne Corp stock. As of the latest transaction made, Ameriprise Financial Inc holds 4,385,593 shares of TECH stock, worth $321 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
4,385,593
Previous 4,102,418 6.9%
Holding current value
$321 Million
Previous $294 Million 19.23%
% of portfolio
0.09%
Previous 0.08%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$70.96 - $82.35 $20.1 Million - $23.3 Million
283,175 Added 6.9%
4,385,593 $350 Million
Q2 2024

Aug 14, 2024

BUY
$62.12 - $84.15 $51 Million - $69.1 Million
821,349 Added 25.03%
4,102,418 $294 Million
Q1 2024

May 15, 2024

BUY
$65.98 - $77.09 $83.1 Million - $97.1 Million
1,259,351 Added 62.29%
3,281,069 $231 Million
Q4 2023

Feb 14, 2024

SELL
$52.83 - $78.22 $7.3 Million - $10.8 Million
-138,237 Reduced 6.4%
2,021,718 $156 Million
Q3 2023

Nov 14, 2023

SELL
$67.52 - $89.42 $68.5 Million - $90.8 Million
-1,015,071 Reduced 31.97%
2,159,955 $147 Million
Q2 2023

Aug 14, 2023

BUY
$73.76 - $85.98 $9.74 Million - $11.3 Million
132,006 Added 4.34%
3,175,026 $259 Million
Q1 2023

May 15, 2023

BUY
$71.62 - $86.62 $40.6 Million - $49.1 Million
566,681 Added 22.88%
3,043,020 $226 Million
Q4 2022

Feb 14, 2023

BUY
$80.67 - $352.29 $150 Million - $655 Million
1,857,914 Added 300.43%
2,476,339 $205 Million
Q3 2022

Nov 14, 2022

SELL
$282.54 - $391.85 $700,416 - $971,396
-2,479 Reduced 0.4%
618,425 $176 Million
Q2 2022

Aug 15, 2022

SELL
$322.67 - $449.65 $1.71 Million - $2.38 Million
-5,302 Reduced 0.85%
620,904 $215 Million
Q1 2022

May 16, 2022

BUY
$353.85 - $487.79 $39 Million - $53.7 Million
110,149 Added 21.34%
626,206 $271 Million
Q4 2021

Feb 14, 2022

BUY
$456.15 - $525.06 $14.2 Million - $16.3 Million
31,132 Added 6.42%
516,057 $267 Million
Q3 2021

Nov 15, 2021

SELL
$444.87 - $538.88 $81 Million - $98.1 Million
-182,029 Reduced 27.29%
484,925 $235 Million
Q2 2021

Aug 16, 2021

BUY
$387.35 - $450.26 $12.9 Million - $15 Million
33,291 Added 5.25%
666,954 $300 Million
Q1 2021

May 17, 2021

SELL
$314.62 - $411.0 $22.8 Million - $29.8 Million
-72,481 Reduced 10.26%
633,663 $242 Million
Q4 2020

Feb 12, 2021

BUY
$246.9 - $321.87 $5.52 Million - $7.2 Million
22,372 Added 3.27%
706,144 $224 Million
Q3 2020

Nov 16, 2020

SELL
$232.22 - $282.96 $7.61 Million - $9.28 Million
-32,781 Reduced 4.57%
683,772 $169 Million
Q2 2020

Aug 14, 2020

BUY
$185.43 - $279.56 $11.7 Million - $17.6 Million
62,839 Added 9.61%
716,553 $189 Million
Q1 2020

May 15, 2020

SELL
$161.17 - $221.51 $11 Million - $15.1 Million
-68,170 Reduced 9.44%
653,714 $124 Million
Q4 2019

Feb 14, 2020

BUY
$189.68 - $222.09 $1.68 Million - $1.97 Million
8,848 Added 1.24%
721,884 $158 Million
Q3 2019

Nov 14, 2019

BUY
$183.56 - $216.72 $22.6 Million - $26.6 Million
122,928 Added 20.83%
713,036 $140 Million
Q2 2019

Aug 14, 2019

BUY
$188.72 - $215.43 $6.73 Million - $7.69 Million
35,679 Added 6.44%
590,108 $123 Million
Q1 2019

May 15, 2019

BUY
$136.09 - $200.44 $9.04 Million - $13.3 Million
66,453 Added 13.62%
554,429 $110 Million
Q4 2018

Feb 14, 2019

SELL
$132.75 - $203.8 $21.6 Million - $33.2 Million
-162,773 Reduced 25.01%
487,976 $70.6 Million
Q3 2018

Nov 14, 2018

SELL
$147.44 - $204.11 $10.8 Million - $15 Million
-73,326 Reduced 10.13%
650,749 $133 Million
Q2 2018

Aug 14, 2018

BUY
$144.9 - $165.58 $38.8 Million - $44.4 Million
267,964 Added 58.75%
724,075 $107 Million
Q1 2018

May 15, 2018

BUY
$131.46 - $151.04 $23 Million - $26.5 Million
175,331 Added 62.44%
456,111 $68.9 Million
Q4 2017

Feb 12, 2018

BUY
$121.17 - $134.75 $9.61 Million - $10.7 Million
79,294 Added 39.35%
280,780 $36.4 Million
Q3 2017

Nov 07, 2017

BUY
$113.59 - $123.78 $22.9 Million - $24.9 Million
201,486
201,486 $24.4 Million

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.87B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.